Winship Cancer Institute of Emory University has been awarded NCI's five-year, $9.7 million Specialized Program of Research Excellence grant to study new approaches for lung cancer treatment.
Joseph A. Sparano will receive the William L. McGuire Memorial Lecture Award at the 2019 San Antonio Breast Cancer Symposium, on Dec. 10-14.
In June, the Multiple Myeloma Research Foundation launched two initiatives, the MMRF CureCloud, and Immune Atlas.
David B. Darr was appointed associate director of administration of the University of North Carolina Lineberger Comprehensive Cancer Center.
The Association of Community Cancer Centers, in collaboration with AstraZeneca, Merck, and partner organizations: the Association for Molecular Pathology, the National Society of Genetic Counselors, and the Society of Gynecologic Oncology, has launched the Barriers to Quality Care in Ovarian Cancer project.
The Wistar Institute has received more than $4.2 million in non-federal funding awarded by private foundations.
Philip Beachy, professor of urology and of developmental biology at the Stanford University School of Medicine, has been awarded the Bladder Cancer Advocacy Network Bladder Cancer Research Innovation Award.
Christopher Thibodeau has been named chief operating officer of OncoCell MDx. He joins Mark McDonough, recently appointed as OncoCell's president, chief executive officer, and member of the board of directors, in strengthening the company's executive leadership team.
The recipients of the Presidential Early Career Award for Scientists and Engineers include four NCI-nominated investigators.
Lori Friedman has been named chief scientific officer at ORIC Pharmaceuticals.
